Alteration of the immune environment in bone marrow from children with recurrent B cell precursor acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Alteration of the immune environment in bone marrow from children with recurrent B cell precursor acute lymphoblastic leukemia

Published:2021-11-29 Issue:1 Volume:113 Page:41-52
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Mikami Takashi¹^ORCID,Kato Itaru¹^ORCID,Wing James Badger²,Ueno Hiroo¹,Tasaka Keiji¹^ORCID,Tanaka Kuniaki¹,Kubota Hirohito¹,Saida Satoshi¹,Umeda Katsutsugu¹^ORCID,Hiramatsu Hidefumi¹,Isobe Tomoya³,Hiwatari Mitsuteru³,Okada Ai⁴,Chiba Kenichi⁴,Shiraishi Yuichi⁴,Tanaka Hiroko⁵,Miyano Satoru⁵,Arakawa Yuki⁶,Oshima Koichi⁶,Koh Katsuyoshi⁶,Adachi Souichi⁷,Iwaisako Keiko⁸,Ogawa Seishi⁹¹⁰¹¹,Sakaguchi Shimon¹²,Takita Junko¹

Affiliation:

1. Department of Pediatrics Graduate School of Medicine Kyoto University Kyoto Japan

2. Laboratory of Human Immunology Immunology Frontier Research Center Osaka University Osaka Japan

3. Department of Pediatrics Graduate School of Medicine The University of Tokyo Tokyo Japan

4. Division of Genome Analysis Platform Development National Cancer Center Research Institute Tokyo Japan

5. M&D Data Science Center Tokyo Medical and Dental University Tokyo Japan

6. Department of Hematology/Oncology Saitama Children’s Medical Center Saitama Japan

7. Department of Human Health Sciences Graduate School of Medicine Kyoto University Kyoto Japan

8. Department of Medical Life Systems Faculty of Life and Medical Sciences Doshisha University Kyoto Japan

9. Department of Pathology and Tumor Biology Graduate School of Medicine Kyoto University Kyoto Japan

10. Department of Molecular Oncology Institute for the Advanced Study of Human Biology (WPI‐ASHBi) Kyoto Japan

11. Department of Medicine Center for Hematology and Regenerative Medicine Karolinska Institute Stockholm Sweden

12. Laboratory of Experimental Immunology Immunology Frontier Research Center Osaka University Osaka Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15186

Reference55 articles.

1. Acute lymphoblastic leukaemia

2. Treatment of Relapsed Precursor-B Acute Lymphoblastic Leukemia With Intensive Chemotherapy

3. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

4. Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

5. A randomized phase 3 trial of Blinatumomab Vs. chemotherapy as post‐reinduction therapy in high and intermediate risk (HR/IR) first relapse of B‐acute lymphoblastic leukemia (B‐ALL) in children and adolescents/young adults (AYAs) demonstrates superior efficacy and tolerability of Blinatumomab: A report from children's oncology group study AALL1331;Patrick AB;Blood,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of Th17 and Treg in Treatment Efficacy and Outcome in Pediatric Acute Lymphoblastic Leukemia;International Journal of Molecular Sciences;2023-08-01

2. IL-10 rs1800896 Polymorphism: A Risk Factor for Adult Acute Lymphoblastic Leukemia;Pharmacogenomics and Personalized Medicine;2022-09